Feed OVID
OV
Ovid Therapeutics Inc.
OVID · NASDAQ
$2.58 -0.58% (-$0.02)
1M +7.82%
Market Cap $489.0M
P/E Ratio -
Div. Yield -
ROE 19.46%
Bulios Fair Price
$3.16
22.5% upside
Preț actual
$2.58
Subevaluat Valoare justă Supraevaluat
Potrivit Bulios Fair Price, acțiunile OVID sunt în prezent subevaluate față de prețul lor de piață. Cum funcționează?
Valuation
27 /100
Expensive P/S 67.43x
P/B 3.74x
P/E N/A
Growth
83 /100
Growing Rev. growth 68.99%
Book val. growth 0.41%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 95.86%
Net margin 240.13%
Op. margin 585.20%
Quality
1 /100
Poor ROIC 29.46%
ROE 19.46%
ROA 11.54%
Debt
100 /100
Low Debt/Equity 0.10x
Current ratio 10.91x
Int. coverage N/A
Stability
26 /100
Unstable Beta 0.23x
Rev. volatility 693.06%
EPS volatility 23.53%
Întreabă StockBot despre OVID
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Margaret Alexander
Employees
23
Headquarters
New York City
Evenimente viitoare
12 AUG.
Earnings
Upcoming earnings report